Investigating the role of VPS4A in blood cell development
Role of VPS4A and ESCRT-III in terminal erythropoiesis
This study is looking at a specific type of anemia caused by genetic issues that affect how your body makes red blood cells, and it aims to understand how a protein called VPS4A plays a role in this process to help find better treatments for people with these blood disorders.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10911266 on NIH RePORTER |
What this research studies
This research focuses on understanding congenital dyserythropoietic anemias (CDAs), which are genetic disorders that affect the production of red blood cells. The study aims to explore the molecular defects associated with these conditions, particularly the role of the VPS4A protein in the process of terminal erythropoiesis, which is the final stage of red blood cell development. By examining mutations in VPS4A, the research seeks to uncover critical pathways that could lead to improved treatments for patients suffering from these blood disorders. The methodology includes genetic analysis and cell culture techniques to investigate how VPS4A interacts with other cellular components involved in red blood cell formation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with congenital dyserythropoietic anemias or related blood disorders.
Not a fit: Patients with non-genetic forms of anemia or those without a diagnosis of congenital dyserythropoietic anemias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential therapies for patients with congenital dyserythropoietic anemias.
How similar studies have performed: Previous research has shown success in understanding similar genetic disorders, but the specific role of VPS4A in CDAs is a novel area of investigation.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Seu, Katie Giger — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Seu, Katie Giger
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.